Skip to content
TrialScanner

NCT00300053

ACT34-CMI -- Adult Autologous CD34+ Cells

Phase 2CompletedLSTALead

Registry record

Lead sponsor
Lisata Therapeutics, Inc.
Conditions
Myocardial Ischemia
Primary completion
Mar 2008Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00300053 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00300053: ACT34-CMI -- Adult Autologous... | TrialScanner